Evidence map›Paper›PMID 32145792›Full record

ArticleLancet (London, England)2020

Challenging the management of drug-resistant tuberculosis.

Hannah Yejin Kim, Scott K Heysell, Stella Mpagama, Ben J Marais, Jan-Willem Alffenaar

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Hannah Yejin KimSydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia; Westmead Hospital, Westmead, Australia. Electronic address: hannah.kim@sydney.edu.au.
Scott K HeysellDivision of Infectious Diseases and International Health, University of Virginia, School of Medicine, Charlottesville, VA, USA.
Stella MpagamaKibong'oto National Tuberculosis Hospital, Sanya Juu, Tanzania.
Ben J MaraisMarie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW 2006, Australia; Department of Infectious Diseases and Microbiology, Children's Hospital at Westmead, Westmead, Australia.
Jan-Willem AlffenaarSydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia; Westmead Hospital, Westmead, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Tuberculosis, Multidrug-ResistantAntitubercular AgentsHumansAntitubercular Agents

Identifiers

PMID32145792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.